Adar1 Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 7,100 shares of SRPT stock, worth $896,659. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,100
Previous 4,450
59.55%
Holding current value
$896,659
Previous $703 Million
26.12%
% of portfolio
0.14%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
84.2MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.3 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.13 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$790 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$550 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$539 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...